Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
621 | 3239 | 46.5 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
141 | 3 | TUBERCULOSIS//INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE//MYCOBACTERIUM TUBERCULOSIS | 64640 |
373 | 2 | MYCOBACTERIUM TUBERCULOSIS//TUBERCULOSIS//INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES | 17241 |
621 | 1 | BCG//TUBERCULOSIS//TUBERCULOSIS VACCINE | 3239 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BCG | authKW | 468608 | 7% | 21% | 239 |
2 | TUBERCULOSIS | authKW | 373532 | 25% | 5% | 796 |
3 | TUBERCULOSIS VACCINE | authKW | 265539 | 1% | 78% | 36 |
4 | MYCOBACTERIA S | address | 233003 | 2% | 32% | 78 |
5 | MYCOBACTERIUM TUBERCULOSIS | authKW | 229278 | 11% | 7% | 353 |
6 | UNITAT TB EXPT | address | 194544 | 1% | 61% | 34 |
7 | AG85B | authKW | 182034 | 1% | 74% | 26 |
8 | TB VACCINE | authKW | 179532 | 1% | 95% | 20 |
9 | SOUTH AFRICAN TB VACCINE INITIAT | address | 157066 | 1% | 56% | 30 |
10 | S AFRICAN TB VACCINE INITIAT | address | 151297 | 1% | 47% | 34 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 72139 | 70% | 0% | 2280 |
2 | Infectious Diseases | 17501 | 22% | 0% | 721 |
3 | Microbiology | 9202 | 23% | 0% | 747 |
4 | Respiratory System | 5749 | 11% | 0% | 370 |
5 | Medicine, Research & Experimental | 4230 | 14% | 0% | 465 |
6 | Cell Biology | 93 | 5% | 0% | 160 |
7 | Parasitiology | 91 | 1% | 0% | 44 |
8 | Biotechnology & Applied Microbiology | 84 | 4% | 0% | 121 |
9 | Virology | 56 | 2% | 0% | 50 |
10 | Tropical Medicine | 45 | 1% | 0% | 25 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MYCOBACTERIA S | 233003 | 2% | 32% | 78 |
2 | UNITAT TB EXPT | 194544 | 1% | 61% | 34 |
3 | SOUTH AFRICAN TB VACCINE INITIAT | 157066 | 1% | 56% | 30 |
4 | S AFRICAN TB VACCINE INITIAT | 151297 | 1% | 47% | 34 |
5 | LANZHOU TB | 136194 | 1% | 85% | 17 |
6 | TB IMMUNOL | 123826 | 1% | 45% | 29 |
7 | JENNER | 117056 | 2% | 17% | 72 |
8 | MICROBIOL IMMUNOL PATHOL | 71911 | 4% | 6% | 121 |
9 | MICROBIAL PATHOGENESIS IMMUN GRP | 57015 | 0% | 55% | 11 |
10 | ABSL 3 | 55966 | 0% | 42% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUBERCULOSIS | 349017 | 7% | 17% | 213 |
2 | VACCINE | 38709 | 8% | 2% | 273 |
3 | INFECTION AND IMMUNITY | 29234 | 9% | 1% | 288 |
4 | CLINICAL AND VACCINE IMMUNOLOGY | 17963 | 2% | 3% | 71 |
5 | MICROBES AND INFECTION | 7914 | 2% | 2% | 50 |
6 | TUBERCLE | 7492 | 1% | 4% | 19 |
7 | SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 7445 | 2% | 1% | 67 |
8 | JOURNAL OF IMMUNOLOGY | 6871 | 6% | 0% | 201 |
9 | TUBERCLE AND LUNG DISEASE | 5392 | 0% | 4% | 16 |
10 | HUMAN VACCINES & IMMUNOTHERAPEUTICS | 5315 | 1% | 2% | 31 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BCG | 468608 | 7% | 21% | 239 | Search BCG | Search BCG |
2 | TUBERCULOSIS | 373532 | 25% | 5% | 796 | Search TUBERCULOSIS | Search TUBERCULOSIS |
3 | TUBERCULOSIS VACCINE | 265539 | 1% | 78% | 36 | Search TUBERCULOSIS+VACCINE | Search TUBERCULOSIS+VACCINE |
4 | MYCOBACTERIUM TUBERCULOSIS | 229278 | 11% | 7% | 353 | Search MYCOBACTERIUM+TUBERCULOSIS | Search MYCOBACTERIUM+TUBERCULOSIS |
5 | AG85B | 182034 | 1% | 74% | 26 | Search AG85B | Search AG85B |
6 | TB VACCINE | 179532 | 1% | 95% | 20 | Search TB+VACCINE | Search TB+VACCINE |
7 | MVA85A | 131958 | 0% | 100% | 14 | Search MVA85A | Search MVA85A |
8 | ESAT 6 | 104588 | 1% | 28% | 39 | Search ESAT+6 | Search ESAT+6 |
9 | HSPX | 88488 | 0% | 72% | 13 | Search HSPX | Search HSPX |
10 | AG85A | 84818 | 0% | 60% | 15 | Search AG85A | Search AG85A |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ORME, IM , (2006) PRECLINICAL TESTING OF NEW VACCINES FOR TUBERCULOSIS: A COMPREHENSIVE REVIEW.VACCINE. VOL. 24. ISSUE 1. P. 2-19 | 127 | 82% | 63 |
2 | JASENOSKY, LD , SCRIBA, TJ , HANEKOM, WA , GOLDFELD, AE , (2015) T CELLS AND ADAPTIVE IMMUNITY TO MYCOBACTERIUM TUBERCULOSIS IN HUMANS.IMMUNOLOGICAL REVIEWS. VOL. 264. ISSUE 1. P. 74 -87 | 108 | 55% | 32 |
3 | PITT, JM , BLANKLEY, S , MCSHANE, H , O'GARRA, A , (2013) VACCINATION AGAINST TUBERCULOSIS: HOW CAN WE BETTER BCG?.MICROBIAL PATHOGENESIS. VOL. 58. ISSUE . P. 2-16 | 131 | 59% | 29 |
4 | OTTENHOFF, THM , KAUFMANN, SHE , (2012) VACCINES AGAINST TUBERCULOSIS: WHERE ARE WE AND WHERE DO WE NEED TO GO?.PLOS PATHOGENS. VOL. 8. ISSUE 5. P. - | 85 | 64% | 142 |
5 | ANDERSEN, P , KAUFMANN, SHE , (2014) NOVEL VACCINATION STRATEGIES AGAINST TUBERCULOSIS.COLD SPRING HARBOR PERSPECTIVES IN MEDICINE. VOL. 4. ISSUE 6. P. - | 92 | 75% | 16 |
6 | O'GARRA, A , REDFORD, PS , MCNAB, FW , BLOOM, CI , WILKINSON, RJ , BERRY, MPR , (2013) THE IMMUNE RESPONSE IN TUBERCULOSIS.ANNUAL REVIEW OF IMMUNOLOGY, VOL 31. VOL. 31. ISSUE . P. 475 -527 | 111 | 34% | 258 |
7 | BEHAR, SM , CARPENTER, SM , BOOTY, MG , BARBER, DL , JAYARAMAN, P , (2014) ORCHESTRATION OF PULMONARY T CELL IMMUNITY DURING MYCOBACTERIUM TUBERCULOSIS INFECTION: IMMUNITY INTERRUPTUS.SEMINARS IN IMMUNOLOGY. VOL. 26. ISSUE 6. P. 559 -577 | 127 | 53% | 14 |
8 | DARRAH, PA , BOLTON, DL , LACKNER, AA , KAUSHAL, D , AYE, PP , MEHRA, S , BLANCHARD, JL , DIDIER, PJ , ROY, CJ , RAO, SS , ET AL (2014) AEROSOL VACCINATION WITH AERAS-402 ELICITS ROBUST CELLULAR IMMUNE RESPONSES IN THE LUNGS OF RHESUS MACAQUES BUT FAILS TO PROTECT AGAINST HIGH-DOSE MYCOBACTERIUM TUBERCULOSIS CHALLENGE.JOURNAL OF IMMUNOLOGY. VOL. 193. ISSUE 4. P. 1799 -1811 | 76 | 79% | 17 |
9 | ROWLAND, R , MCSHANE, H , (2011) TUBERCULOSIS VACCINES IN CLINICAL TRIALS.EXPERT REVIEW OF VACCINES. VOL. 10. ISSUE 5. P. 645-658 | 89 | 67% | 52 |
10 | GUPTA, UD , KATOCH, VM , MCMURRAY, DN , (2007) CURRENT STATUS OF TB VACCINES.VACCINE. VOL. 25. ISSUE 19. P. 3742-3751 | 86 | 83% | 49 |
Classes with closest relation at Level 1 |